Increased serum-soluble interleukin-5 receptor alpha level precedes the development of eczema in children

Pediatric Allergy and Immunology

Volumn 21, Issue 7, 2010, Pages 1052-1058

  Semic Jusufagic, Aida ^a   Gevaert, Philippe ^b   Bachert, Claus ^b   Murray, Clare ^a   Simpson, Angela ^a   Custovic, Adnan ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Birth cohort; Children; Eczema; Soluble IL 5R

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 5 RECEPTOR ALPHA; PROTEIN; UNCLASSIFIED DRUG; URINARY EOSINOPHILIC PROTEIN X;

ANALYSIS OF VARIANCE; ARTICLE; ATOPY; CHILD; CONTROLLED STUDY; DISEASE COURSE; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIZATION; WHEEZING;

AGE OF ONSET; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ECZEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN-5 RECEPTOR ALPHA SUBUNIT; MALE; PROGNOSIS; RESPIRATORY SOUNDS; RHINITIS;

EID: 77958557564     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/j.1399-3038.2010.01077.x     Document Type: Article

References (23)

1. Wedi B, Raap U, Lewrick H, Kapp A. Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol 1997: 100: 536-43.
2. Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997: 158: 3902-8.
3. Tavernier J, Devos R, Cornelis S, et al. A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell 1991: 66: 1175-84.
4. Ishino T, Pasut G, Scibek J, Chaiken I. Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognition. J Biol Chem 2004: 279: 9547-56.
5. Bystrom J, Dyer KD, Ting-De Ravin SS, et al. Interleukin-5 does not influence differential transcription of transmembrane and soluble isoforms of IL-5R alpha in vivo. Eur J Haematol 2006: 77: 181-90.
6. Tavernier J, Van der Heyden J, Verhee A, et al. Interleukin 5 regulates the isoform expression of its own receptor alpha-subunit. Blood 2000: 95: 1600-7.
7. Foster PS, Mould AW, Yang M, et al. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 2001: 179: 173-81.
8. Roboz GJ, Rafii S. Interleukin-5 and the regulation of eosinophil production. Curr Opin Hematol 1999: 6: 164-8.
9. Cameron L, Christodoulopoulos P, Lavigne F, et al. Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor. J Immunol 2000: 164: 1538-45.
10. Gevaert P, Hellman C, Lundblad L, et al. Differential expression of the interleukin 5 receptor alpha isoforms in blood and tissue eosinophils of nasal polyp patients. Allergy 2009: 64: 725-32.
11. Gevaert P, Bachert C, Holtappels G, et al. Enhanced soluble interleukin-5 receptor alpha expression in nasal polyposis. Allergy 2003: 58: 371-9.
12. Liu LY, Sedgwick JB, Bates ME, et al. Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol 2002: 169: 6452-8.
13. Yasruel Z, Humbert M, Kotsimbos TC, et al. Membrane-bound and soluble alpha IL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics. Am J Respir Crit Care Med 1997: 155: 1413-8.
14. Gore C, Peterson CG, Kissen P, et al. Urinary eosinophilic protein X, atopy, and symptoms suggestive of allergic disease at 3-years of age. J Allergy Clin Immunol 2003: 112: 702-8.
15. Oymar K, Bjerknes R. Urinary eosinophil protein X in children with atopic dermatitis: relation to atopy and disease activity. Allergy 2000: 55: 964-8.
16. Custovic A, Simpson BM, Murray CS, Lowe L, Woodcock A. The National Asthma Campaign Manchester Asthma and Allergy Study. Pediatr Allergy Immunol 2002: 13 (Suppl. 15): 32-7.
17. Lowe L, Murray CS, Custovic A, Simpson BM, Kissen PM, Woodcock A. Specific airway resistance in 3-year-old children: a prospective cohort study. Lancet 2002: 359: 1904-8.
18. Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995: 8: 483-91.
19. Custovic A, Simpson BM, Simpson A, Kissen P, Woodcock A. Effect of environmental manipulation in pregnancy and early life on respiratory symptoms and atopy during first year of life: a randomised trial. Lancet 2001: 358: 188-93.
20. Woodcock A, Lowe LA, Murray CS, et al. Early life environmental control: effect on symptoms, sensitization, and lung function at age 3-years. Am J Respir Crit Care Med 2004: 170: 433-9.
21. Namkung JH, Lee JE, Kim E, et al. IL-5 and IL-5 receptor alpha polymorphisms are associated with atopic dermatitis in Koreans. Allergy 2007: 62: 934-42.
22. Tavernier J, Tuypens T, Plaetinck G, Verhee A, Fiers W, Devos R. Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. Proc Natl Acad Sci U S A 1992: 89: 7041-5.
23. Sehmi R, Wood LJ, Watson R, et al. Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation. J Clin Invest 1997: 100: 2466-75.